Tag: Khiron Life Sciences
Khiron Life Sciences Announces Terms of Overnight Marketed Offering TORONTO, July 6, 2021 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF), is pleased...
Khiron Life Sciences Announces Closing of $14.49 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron”...
After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing TORONTO, May 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the...
KCSA’s Cynthia Salarizadeh also to participate in an in-depth panel discussion focused on advertising and marketing NEW YORK, Oct. 9, 2018 /PRNewswire/ — KCSA Strategic Communications (KCSA), a fully...
Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs TORONTO, Sept. 26, 2018 /CNW/ – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) has completed the quarterly rebalance of the constituent holdings of...
Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN,...
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 23, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ,...
Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
TORONTO, Aug. 15, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQB: KHRNF), a Canadian integrated medical cannabis company with its core operations in...
Khiron Signs Letter of Intent to Acquire Colombia’s Leading Health Network Acquisition to deliver network of 100,000 patients that meet Khiron’s indicated targets TORONTO, Aug. 7, 2018 /CNW/ –...
Increased capacity to meet market demand and advance the Company’s objective of addressing the medical needs of 1 million patients in Latin America TORONTO, Aug. 2, 2018 /CNW/ – Khiron Life Sciences Corp....
Benzinga, a financial media company that has developed a highly successful FinTech conference and that offers extensive cannabis industry coverage, will be presenting the Cannabis Capital Conference in Toronto...
Appointment expands business and political network and furthers development of medical cannabis education and research across Latin America TORONTO, July 17, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron”...
TORONTO, June 26, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Medical Cannabis, Pain and Palliative Care Physician/Researcher will oversee Khiron’s product development and physician’s educational program TORONTO, June 25, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the...
President-Elect’s platform promises significant economic measures to increase foreign investment and international trade TORONTO, June 21, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN),...
Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets TORONTO, June...
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia Colombian Agricultural Institute (“ICA”) authorization is a significant requirement to...
The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...
Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...
Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
